HEPATIC EXPRESSION OF A RECEPTOR-BINDING-DEFECTIVE HUMAN APOLIPOPROTEIN-E VARIANT CREATES A MODEL OF TYPE-III HYPERLIPOPROTEINEMIA IN TRANSGENIC MICE

被引：0
|
作者：
FAZIO, S [1 ]
SIMONET, WS [1 ]
RALL, SC [1 ]
机构：
[1] UNIV CALIF SAN FRANCISCO,GLADSTONE INST CARDIOVASC DIS,SAN FRANCISCO,CA 94143
来源：
CIRCULATION | 1992年 / 86卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 278
页数：1
相关论文
共 50 条
  • [21] RARE APOLIPOPROTEIN-E VARIANT IDENTIFIED IN A PATIENT WITH TYPE-III HYPERLIPEMIA
    WENHAM, PR
    MCDOWELL, IFW
    HODGES, VM
    MCENENY, J
    OKANE, MJ
    DAVIES, RJH
    NICHOLLS, DP
    TRIMBLE, ER
    BLUNDELL, G
    ATHEROSCLEROSIS, 1993, 99 (02) : 261 - 271
  • [22] DEFECTIVE RECEPTOR-BINDING OF BETA-VLDL IN TYPE-III HYPERLIPOPROTEINEMIA DUE TO ABNORMAL APOLIPOPROTEIN-E2
    HUI, DY
    INNERARITY, TL
    MAHLEY, RW
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 1061 - 1061
  • [23] RESTRICTION ISOTYPING OF APOLIPOPROTEIN-E R145C IN TYPE-III HYPERLIPOPROTEINEMIA
    HSIA, SH
    CONNELLY, PW
    HEGELE, RA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1995, 43 (02) : 187 - 194
  • [24] APOLIPOPROTEIN-E(2) ISOFORMS OF DIFFERENT MOBILITY - A NOVEL CAUSE OF TYPE-III HYPERLIPOPROTEINEMIA
    WILE, D
    NITHTHYANANTHAN, S
    TRAYNER, I
    SOUTAR, AK
    THOMPSON, GR
    ATHEROSCLEROSIS, 1991, 90 (2-3) : 223 - 223
  • [25] APOLIPOPROTEIN-E - (ROLE IN LIPOPROTEIN METABOLISM AND PATHO-PHYSIOLOGY OF HYPERLIPOPROTEINEMIA TYPE-III)
    UTERMANN, G
    RICERCA IN CLINICA E IN LABORATORIO, 1982, 12 (01): : 23 - 33
  • [26] Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia
    Dong, LM
    Parkin, S
    Trakhanov, SD
    Rupp, B
    Simmons, T
    Arnold, KS
    Newhouse, YM
    Innerarity, TL
    Weisgraber, KH
    NATURE STRUCTURAL BIOLOGY, 1996, 3 (08): : 718 - 722
  • [27] NORMOLIPEMIC DYSBETALIPOPROTEINEMIA AND HYPERLIPOPROTEINEMIA TYPE-III IN SUBJECTS HOMOZYGOUS FOR A RARE GENETIC APOLIPOPROTEIN-E VARIANT (APOE1)
    STEINMETZ, A
    ASSEFBARKHI, N
    ELTZE, C
    EHLENZ, K
    FUNKE, H
    PIES, A
    ASSMANN, G
    KAFFARNIK, H
    JOURNAL OF LIPID RESEARCH, 1990, 31 (06) : 1005 - 1013
  • [28] THE FUNCTIONAL-CHARACTERISTICS OF A HUMAN APOLIPOPROTEIN-E VARIANT (CYSTEINE AT RESIDUE-142) MAY EXPLAIN ITS ASSOCIATION WITH DOMINANT EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA
    HORIE, Y
    FAZIO, S
    WESTERLUND, JR
    WEISGRABER, KH
    RALL, SC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (03) : 1962 - 1968
  • [29] SERUM AND INTERSTITIAL FLUID APOLIPOPROTEIN-E LEVELS IN THE HEALTHY AND IN HYPERLIPOPROTEINEMIA TYPE-III AS STUDIED BY RADIOIMMUNOASSAY
    GUSTAFSON, S
    VESSBY, B
    OSTLUNDLINDQVIST, AM
    CLINICA CHIMICA ACTA, 1985, 151 (01) : 49 - 59
  • [30] APOLIPOPROTEIN-E2 ABNORMALITY IN TYPE-III HYPERLIPOPROTEINEMIA - MODULATION OF THE RECEPTOR-BINDING DOMAIN
    INNERARITY, TL
    WEISGRABER, KH
    RALL, SC
    MAHLEY, RW
    CLINICAL RESEARCH, 1983, 31 (02): : A460 - A460
12345